A detailed history of Summit Financial, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Summit Financial, LLC holds 10,318 shares of ZTS stock, worth $1.84 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
10,318
Previous 10,412 0.9%
Holding current value
$1.84 Million
Previous $1.76 Million 1.53%
% of portfolio
0.08%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$145.54 - $178.83 $13,680 - $16,810
-94 Reduced 0.9%
10,318 $1.79 Million
Q1 2024

Apr 24, 2024

BUY
$165.67 - $199.94 $343,930 - $415,075
2,076 Added 24.9%
10,412 $1.76 Million
Q4 2023

Feb 05, 2024

BUY
$151.44 - $200.09 $7,269 - $9,604
48 Added 0.58%
8,336 $1.65 Million
Q3 2023

Nov 07, 2023

BUY
$167.14 - $192.77 $163,964 - $189,107
981 Added 13.43%
8,288 $1.44 Million
Q2 2023

Aug 11, 2023

SELL
$160.94 - $186.23 $113,462 - $131,292
-705 Reduced 8.8%
7,307 $1.26 Million
Q1 2023

May 03, 2023

BUY
$145.48 - $175.02 $40,588 - $48,830
279 Added 3.61%
8,012 $1.33 Million
Q4 2022

Feb 07, 2023

SELL
$131.14 - $157.47 $149,368 - $179,358
-1,139 Reduced 12.84%
7,733 $1.13 Million
Q3 2022

Nov 15, 2022

BUY
$148.29 - $182.55 $193,815 - $238,592
1,307 Added 17.28%
8,872 $1.32 Billion
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $139,281 - $178,680
-893 Reduced 10.56%
7,565 $1.3 Million
Q1 2022

May 10, 2022

BUY
$181.39 - $234.03 $24,850 - $32,062
137 Added 1.65%
8,458 $1.6 Million
Q4 2021

Feb 07, 2022

BUY
$193.69 - $247.03 $20,337 - $25,938
105 Added 1.28%
8,321 $2.03 Million
Q3 2021

Nov 08, 2021

BUY
$189.29 - $209.69 $1.21 Million - $1.34 Million
6,399 Added 352.17%
8,216 $1.6 Million
Q2 2021

Aug 06, 2021

BUY
$155.9 - $187.99 $283,270 - $341,577
1,817 New
1,817 $338,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Summit Financial, LLC Portfolio

Follow Summit Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial, LLC with notifications on news.